Total Payments
$65,472
2024 Payments
$28,897
Companies
21
Transactions
271
Medicare Patients
2,804
Medicare Billing
$341,320
Payment Breakdown by Category
Other$53,332 (81.5%)
Food & Beverage$6,147 (9.4%)
Travel$4,001 (6.1%)
Consulting$1,992 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,300 | 29 | 81.4% |
| Food and Beverage | $6,147 | 210 | 9.4% |
| Travel and Lodging | $4,001 | 28 | 6.1% |
| Consulting Fee | $1,992 | 2 | 3.0% |
| Entertainment | $31.57 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $32,112 | 94 | $0 (2020) |
| Phathom Pharmaceuticals, Inc. | $27,776 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,532 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $821.57 | 21 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $468.78 | 30 | $0 (2022) |
| Janssen Biotech, Inc. | $357.54 | 17 | $0 (2024) |
| ABBVIE INC. | $320.89 | 12 | $0 (2024) |
| Shire North American Group Inc | $200.00 | 1 | $0 (2018) |
| Mauna Kea Technologies, Inc. | $176.89 | 5 | $0 (2024) |
| Braintree Laboratories, Inc. | $156.15 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,897 | 73 | Phathom Pharmaceuticals, Inc. ($27,776) |
| 2023 | $448.23 | 17 | Janssen Biotech, Inc. ($176.45) |
| 2022 | $2,099 | 12 | AstraZeneca Pharmaceuticals LP ($1,858) |
| 2021 | $184.33 | 5 | Mauna Kea Technologies, Inc. ($103.57) |
| 2020 | $2,234 | 15 | Allergan, Inc. ($2,026) |
| 2019 | $9,288 | 63 | Allergan Inc. ($8,564) |
| 2018 | $17,307 | 55 | Allergan Inc. ($16,849) |
| 2017 | $5,015 | 31 | Allergan Inc. ($4,673) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $125.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $29.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $55.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $346.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $306.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $118.46 | General |
| 06/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $104.11 | General |
| 06/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $36.84 | General |
| Category: Respiratory | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $121.02 | General |
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $49.45 | General |
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $37.82 | General |
| 05/21/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 668 | 736 | $616,170 | $78,046 |
| 2022 | 11 | 706 | 762 | $587,424 | $85,961 |
| 2021 | 10 | 756 | 844 | $581,616 | $96,951 |
| 2020 | 12 | 674 | 748 | $512,451 | $80,361 |
Total Patients
2,804
Total Services
3,090
Medicare Billing
$341,320
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 162 | 163 | $213,856 | $16,448 | 7.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 74 | 75 | $126,675 | $15,298 | 12.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 99 | $24,552 | $9,591 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $27,808 | $9,004 | 32.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 126 | 134 | $132,928 | $7,660 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 85 | $22,015 | $7,557 | 34.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $15,295 | $4,769 | 31.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 24 | 27 | $29,403 | $3,846 | 13.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $23,220 | $3,731 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 19 | $418.00 | $142.80 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 134 | 134 | $47,168 | $17,685 | 37.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 158 | 158 | $207,296 | $16,872 | 8.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 57 | 57 | $96,273 | $11,987 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 117 | $27,495 | $11,704 | 42.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 120 | 130 | $128,960 | $9,268 | 7.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $13,110 | $4,921 | 37.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 58 | $13,978 | $4,859 | 34.8% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 21 | $22,869 | $3,005 | 13.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $22,439 | $2,820 | 12.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 27 | $4,536 | $1,600 | 35.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,300 | $1,241 | 37.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 154 | 154 | $52,514 | $22,871 | 43.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 163 | 163 | $213,856 | $18,700 | 8.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 122 | $27,328 | $12,200 | 44.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 61 | 61 | $103,451 | $11,152 | 10.8% |
About Dr. Amar Bansal, M.D
Dr. Amar Bansal, M.D is a Gastroenterology healthcare provider based in Aurora, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710929716.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amar Bansal, M.D has received a total of $65,472 in payments from pharmaceutical and medical device companies, with $28,897 received in 2024. These payments were reported across 271 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($53,300).
As a Medicare-enrolled provider, Bansal has provided services to 2,804 Medicare beneficiaries, totaling 3,090 services with total Medicare billing of $341,320. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Aurora, IL
- Active Since 06/12/2006
- Last Updated 11/18/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1710929716
Products in Payments
- VOQUEZNA (Drug) $27,776
- LINZESS (Drug) $27,015
- VIBERZI (Drug) $5,101
- FASENRA (Biological) $1,845
- ENTYVIO (Biological) $427.92
- Entyvio (Biological) $393.65
- STELARA (Biological) $357.54
- XIFAXAN (Drug) $353.88
- RINVOQ (Biological) $186.58
- XELJANZ (Drug) $129.93
- Cologuard Collection Kit (Device) $108.09
- SUPREP (Drug) $84.82
- Haegarda (Biological) $83.34
- DUPIXENT (Biological) $76.86
- TRULANCE (Drug) $70.73
- MOTOFEN (Drug) $59.95
- ESOPHYX (Device) $52.74
- MAVYRET (Drug) $47.46
- CREON (Drug) $33.17
- UCERIS (Drug) $27.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Aurora
Dr. Steven Edmundowicz, Md, MD
Gastroenterology — Payments: $229,083
Gastroenterology $229,083
Mihir Wagh, Md, MD
Gastroenterology — Payments: $199,297
Gastroenterology $199,297
Raj Shah, Md, MD
Gastroenterology — Payments: $146,129
Gastroenterology $146,129
Dr. Rachna Arora, M.d, M.D
Gastroenterology — Payments: $90,741
Gastroenterology $90,741
Jennifer Christie, Md, MD
Gastroenterology — Payments: $55,237
Gastroenterology $55,237
Dr. Sachin Wani, Md, MD
Gastroenterology — Payments: $46,769
Gastroenterology $46,769